{"id":"W2226900876","doi":"10.1200/jco.2014.32.26_suppl.152","title":"Everolimus plus exemestane in patients with advanced invasive lobular carcinoma: Efficacy and safety results from BOLERO-2.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Everolimus; Exemestane; Internal medicine; Hazard ratio; Population; Oncology; Gastroenterology; Urology; Breast cancer; Cancer; Aromatase; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001064656,0.0005706031,0.001338335,0.0003075486,0.0001766494,0.0005733744,0.0005090284,0.000470544,0.002600762],"category_scores_gemma":[0.0008655541,0.0003117896,0.001207055,0.0003365258,0.0004482831,0.0004070169,0.0003785959,0.001268073,0.0003748424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007619841,"about_ca_system_score_gemma":0.0008312025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008601262,"about_ca_topic_score_gemma":0.003881507,"domain_scores_codex":[0.9997222,0.000137868,0.00002508202,0.00004045734,0.00003399239,0.00004044746],"domain_scores_gemma":[0.9995279,0.0001062203,0.0001549156,0.00003040795,0.00001775333,0.0001627885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8539138,0.01690242,0.01172268,0.001452986,0.002908763,0.0002151693,0.000185528,0.001374523,0.01834289,0.0001352345,0.001625104,0.09122088],"study_design_scores_gemma":[0.6206817,0.314941,0.05296911,0.0001770641,0.002438165,0.0004801287,0.00007705099,0.0007678401,0.002511042,0.0001219599,0.004798152,0.00003684227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884885,0.007889557,0.0001373991,0.0002312291,0.00004611168,0.0006190803,0.0008115256,0.00002469084,0.001751873],"genre_scores_gemma":[0.9895698,0.005222243,0.000609828,0.0005529993,0.0001049104,0.0005280644,0.001858343,0.00001025214,0.001543629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002600762,"threshold_uncertainty_score":0.00870043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03551557660039675,"score_gpt":0.3611832219876269,"score_spread":0.3256676453872302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}